Medtronic Faces Legal Challenge in Insulin Pump Litigation

A Los Angeles Superior Court judge has denied Medtronic Inc's motions for summary judgment in two separate lawsuits involving its MiniMed insulin pump systems, allowing the cases to proceed to trial on July 21, 2025. The ruling represents a significant legal victory for the plaintiffs and their legal representation at Cowper Law LLP.

Judge Elihu Berle's comprehensive order suggests that Medtronic may have knowingly concealed critical information about defective retainer rings in its insulin pump systems. The court found substantial evidence indicating that Medtronic was aware of potential defects as early as 2016, with internal documents potentially demonstrating the company's knowledge of risks and potential widespread impact.

The judge's ruling hinged on evidence that Medtronic might have intentionally concealed product defects to continue selling insulin pump systems and avoid potential liability. The court's assessment implies that the plaintiffs could have reasonably relied on the company's alleged concealment, a crucial finding that allows the litigation to move forward.

Cowper Law LLP represents over a thousand Type-I diabetics who used the FDA Class 1 recalled Medtronic 600-series insulin pumps. The litigation could potentially result in significant financial and reputational consequences for Medtronic, highlighting the importance of medical device manufacturers' transparency and accountability.

The cases underscore the critical need for rigorous safety protocols in medical device manufacturing and the legal system's role in holding companies accountable for potential product defects that could harm patients.